-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) is an immune- mediated recurrent gastrointestinal (GI) inflammatory disease characterized by repeated alternating periods of chronic tissue damage and acute exacerbations
.
IBD includes ulcerative colitis (UC) and Crohn's disease (CD), well-known, inflammatory autoimmune diseases (e.
Inflammatory bowel disease (IBD) is an immune- mediated recurrent gastrointestinal (GI) inflammatory disease characterized by repeated alternating periods of chronic tissue damage and acute exacerbations
Researchers conducted a cross-sectional study using data from a sample of hospitalized patients across the United States from 1998 to 2010
.
The ICD-9-CM code is used to identify confirmed patients with Crohn's disease (CD) (555.
Ulcerative colitis statistics
A total of 2,629,161 MI patients were enrolled in this study, including 3,607 UC and 3784 CD patients
.
UC ([OR], 1.
This study shows that IBD does not affect the hospital mortality of MI
.
However, MI patients with IBD have longer LOS
This study shows that IBD does not affect the hospital mortality of MI
Preetika Sinh.
Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
Leave a message here